• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过线粒体信号通路进行癌症治疗的硫卡巴腙金属配合物的最新进展

Recent progress in thiocarbazone metal complexes for cancer therapy via mitochondrial signalling pathway.

作者信息

Zheng Yunyun, An Hangyi, Qi Jinxu, Li Jiaming

机构信息

Medical School of Pingdingshan University, Pingdingshan, China.

Guangxi Key Laboratory of Green Chemical Materials and Safety Technology, College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou, China.

出版信息

Front Chem. 2024 May 30;12:1424022. doi: 10.3389/fchem.2024.1424022. eCollection 2024.

DOI:10.3389/fchem.2024.1424022
PMID:38873408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11169589/
Abstract

Mitochondria are the energy factories of cells and are important targets for the development of novel tumour treatment strategies owing to their involvement in processes such as apoptosis, oxidative stress, and metabolic programming. Thiosemicarbazone metal complexes target mitochondria and reduce mitochondrial membrane potential. The breakdown of mitochondrial membrane potential is a key event in the early stage of apoptosis, which releases cytochrome C and other pro-apoptotic factors, activates the intracellular apoptotic enzyme cascade, and eventually causes irreversible apoptosis of tumour cells. Thiosemicarbazone metal complexes targeting the mitochondria have recently emerged as potential antitumour agents; therefore, this review describes the structural diversity of thiosemicarbazone metal [Fe(III), Cu(II), Ni(II), Zn(II), Ga(III), Pb(II), Au(III), and Ir(III)] complexes and explores their anti-tumour mechanisms that target mitochondrial pathways.

摘要

线粒体是细胞的能量工厂,由于其参与细胞凋亡、氧化应激和代谢编程等过程,成为新型肿瘤治疗策略开发的重要靶点。硫代卡巴腙金属配合物靶向线粒体并降低线粒体膜电位。线粒体膜电位的破坏是细胞凋亡早期的关键事件,它释放细胞色素C和其他促凋亡因子,激活细胞内凋亡酶级联反应,最终导致肿瘤细胞发生不可逆的凋亡。靶向线粒体的硫代卡巴腙金属配合物最近已成为潜在的抗肿瘤药物;因此,本综述描述了硫代卡巴腙金属[铁(III)、铜(II)、镍(II)、锌(II)、镓(III)、铅(II)、金(III)和铱(III)]配合物的结构多样性,并探讨了它们靶向线粒体途径的抗肿瘤机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0bb/11169589/f3f2f5876249/fchem-12-1424022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0bb/11169589/c530335c1b33/fchem-12-1424022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0bb/11169589/f3f2f5876249/fchem-12-1424022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0bb/11169589/c530335c1b33/fchem-12-1424022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0bb/11169589/f3f2f5876249/fchem-12-1424022-g002.jpg

相似文献

1
Recent progress in thiocarbazone metal complexes for cancer therapy via mitochondrial signalling pathway.通过线粒体信号通路进行癌症治疗的硫卡巴腙金属配合物的最新进展
Front Chem. 2024 May 30;12:1424022. doi: 10.3389/fchem.2024.1424022. eCollection 2024.
2
Differential transmetallation of complexes of the anti-cancer thiosemicarbazone, Dp4e4mT: effects on anti-proliferative efficacy, redox activity, oxy-myoglobin and oxy-hemoglobin oxidation.抗癌硫代卡巴腙配合物Dp4e4mT的差异金属转移:对抗增殖功效、氧化还原活性、氧合肌红蛋白和氧合血红蛋白氧化的影响
Chem Sci. 2023 Dec 15;15(3):974-990. doi: 10.1039/d3sc05723b. eCollection 2024 Jan 17.
3
Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway.通过内质网应激-线粒体功能障碍途径诱导 SGC-7901 细胞凋亡的铱(III)配合物。
J Biol Inorg Chem. 2022 Aug;27(4-5):455-469. doi: 10.1007/s00775-022-01943-6. Epub 2022 Jul 11.
4
Mitochondria-Targeting Anticancer Metal Complexes.线粒体靶向抗癌金属配合物。
Curr Med Chem. 2019;26(4):694-728. doi: 10.2174/0929867325666180307112029.
5
Single-crystal structure and intracellular localization of Zn(II)-thiosemicarbazone complex targeting mitochondrial apoptosis pathways.靶向线粒体凋亡途径的Zn(II)-硫代氨基脲配合物的单晶结构及细胞内定位
Bioorg Med Chem Lett. 2020 Aug 15;30(16):127340. doi: 10.1016/j.bmcl.2020.127340. Epub 2020 Jun 9.
6
New Mononuclear and Binuclear Cu(II), Co(II), Ni(II), and Zn(II) Thiosemicarbazone Complexes with Potential Biological Activity: Antimicrobial and Molecular Docking Study.新型单核和双核 Cu(II)、Co(II)、Ni(II) 和 Zn(II) 缩硫代卡巴腙配合物的潜在生物活性:抗菌和分子对接研究。
Molecules. 2021 Apr 15;26(8):2288. doi: 10.3390/molecules26082288.
7
Metal-complexes as ligands to generate asymmetric homo- and heterodinuclear M(A)(III)M(B)(II) species: a magneto-structural and spectroscopic comparison of imidazole-N versus pyridine-N.金属配合物作为配体生成不对称同核和异核 M(A)(III)M(B)(II)物种:咪唑-N 与吡啶-N 的磁结构和光谱比较。
Inorg Chem. 2010 Jan 18;49(2):626-41. doi: 10.1021/ic9018426.
8
Thiosemicarbazone N-Heterocyclic Cu(II) complexes inducing nuclei DNA and mitochondria damage in hepatocellular carcinoma cells.噻唑烷酮类 N-杂环 Cu(II)配合物诱导肝癌细胞细胞核和线粒体损伤。
J Inorg Biochem. 2022 Nov;236:111964. doi: 10.1016/j.jinorgbio.2022.111964. Epub 2022 Aug 13.
9
Non-substituted N-heteroaromatic selenosemicarbazone metal complexes induce apoptosis in cancer cells via activation of mitochondrial pathway.未取代的 N-杂芳基硒代缩氨基脲金属配合物通过激活线粒体途径诱导癌细胞凋亡。
Eur J Med Chem. 2011 Sep;46(9):3734-47. doi: 10.1016/j.ejmech.2011.05.039. Epub 2011 May 24.
10
Comparative evaluation of the structure and antitumor mechanism of mononuclear and trinucleated thiosemicarbazone Cu(II) complexes.单核和三核硫代卡巴腙铜(II)配合物的结构与抗肿瘤机制的比较评价
J Inorg Biochem. 2023 Mar;240:112116. doi: 10.1016/j.jinorgbio.2022.112116. Epub 2022 Dec 29.

引用本文的文献

1
Thiosemicarbazone-Based Compounds: Cancer Cell Inhibitors with Antioxidant Properties.基于硫代卡巴腙的化合物:具有抗氧化特性的癌细胞抑制剂。
Molecules. 2025 May 7;30(9):2077. doi: 10.3390/molecules30092077.

本文引用的文献

1
Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium(III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune Response.设计一种靶向线粒体的治疗一体多功能金属铱(III)配合物:通过坏死性凋亡和免疫反应克服顺铂耐药性并抑制肿瘤转移。
J Med Chem. 2024 Mar 14;67(5):3843-3859. doi: 10.1021/acs.jmedchem.3c02227. Epub 2024 Mar 5.
2
Quercetin and tanshinone prevent mitochondria from oxidation and autophagy to inhibit KGN cell apoptosis through the SIRT1/SIRT3-FOXO3a axis.槲皮素和丹参酮通过 SIRT1/SIRT3-FOXO3a 轴防止线粒体氧化和自噬来抑制 KGN 细胞凋亡。
Cell Mol Biol (Noisy-le-grand). 2024 Feb 29;70(2):257-263. doi: 10.14715/cmb/2024.70.2.36.
3
Breast Cancer: Mitochondria-Centered Metabolic Alterations in Tumor and Associated Adipose Tissue.
乳腺癌:肿瘤和相关脂肪组织中线粒体为中心的代谢改变。
Cells. 2024 Jan 15;13(2):155. doi: 10.3390/cells13020155.
4
Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes.金属硫代半卡巴腙配合物对拓扑异构酶的抑制作用。
Int J Mol Sci. 2023 Jul 27;24(15):12010. doi: 10.3390/ijms241512010.
5
Orotic acid induces apoptotic death in ovarian adult granulosa tumour cells and increases mitochondrial activity in normal ovarian granulosa cells.乳清酸诱导卵巢成年颗粒细胞瘤细胞凋亡,并增加正常卵巢颗粒细胞中的线粒体活性。
Reprod Biol. 2023 Sep;23(3):100790. doi: 10.1016/j.repbio.2023.100790. Epub 2023 Jul 19.
6
Bioactive Thiosemicarbazone Coordination Metal Complexes: Synthesis, Characterization, Theoretical analysis, Biological Activity, Molecular Docking and ADME analysis.生物活性硫代卡巴腙配位金属配合物的合成、表征、理论分析、生物活性、分子对接和 ADME 分析。
Chem Biodivers. 2023 Aug;20(8):e202300760. doi: 10.1002/cbdv.202300760. Epub 2023 Jul 24.
7
Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin.基于人血清白蛋白 IIA 亚结构域中 His-242 残基开发一种多靶标抗癌钯(II)试剂。
J Med Chem. 2023 Jul 13;66(13):8564-8579. doi: 10.1021/acs.jmedchem.3c00248. Epub 2023 Jun 15.
8
Modulation of Transcription Profile Induced by Antiproliferative Thiosemicarbazone Metal Complexes in U937 Cancer Cells.抗增殖硫代氨基脲金属配合物诱导U937癌细胞转录谱的调控
Pharmaceutics. 2023 Apr 24;15(5):1325. doi: 10.3390/pharmaceutics15051325.
9
Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice.矢车菊素通过激活AMPK-α/UCP2轴减轻线粒体功能障碍和ROS积累,从而抵抗SAE小鼠的炎症和凋亡。
Front Pharmacol. 2023 Jan 9;13:1038802. doi: 10.3389/fphar.2022.1038802. eCollection 2022.
10
Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer.基于肿瘤微环境和乳铁蛋白特性开发镓(III)制剂:实现癌症的双药共递送和多靶点联合治疗
J Med Chem. 2023 Jan 12;66(1):793-803. doi: 10.1021/acs.jmedchem.2c01684. Epub 2022 Dec 21.